Transfemoral transcatheter aortic valve implantation in the presence of a mechanical mitral valve prosthesis using a dedicated TAVI guidewire: utility of a patient-specific three-dimensional heart model [0.03%]
存在机械二尖瓣的情况下的经股经导管主动脉瓣植入术及专用TAVI导丝：个性化三维心脏模型的使用价值
Takanari Fujita,Naritatsu Saito,Kenji Minakata et al.
Takanari Fujita et al.
An 82-year-old woman with severe aortic stenosis was referred. She had previously undergone mitral valve replacement. We planned transcatheter aortic valve implantation (TAVI) with transfemoral approach. We planned to use the Safari-dedicat...
Nine-year follow-up of progressive peri-stent contrast staining after Cypher sirolimus-eluting stent implantation: a case report [0.03%]
药物洗脱支架植入术后进展性支架周边造影剂着染9年随访一例报告
Masayuki Hyogo,Takahisa Sawada,Jun Shiraishi et al.
Masayuki Hyogo et al.
A 62-year-old male underwent three percutaneous coronary interventions involving four bare metal stents and six Cypher sirolimus-eluting stents within 1 month. At the latest coronary angiographic examination, all of the Cypher stents, but n...
Treat-to-target lipid control is effective but highlighted poor prognosis without indication of statin following percutaneous coronary intervention [0.03%]
基于靶目标的血脂治疗有效但冠脉介入术后无适应证使用他汀预后不良
Shigemitsu Tanaka,Yuji Ikari,Takeshi Ijichi et al.
Shigemitsu Tanaka et al.
A reduction of low-density lipoprotein cholesterol (LDL-C) is important for the secondary prevention of coronary artery disease. We performed secondary prevention in 632 consecutive patients, including 315 with acute coronary syndrome, who ...
Intracoronary versus Intravenous eptifibatide during percutaneous coronary intervention for acute ST-segment elevation myocardial infarction; a randomized controlled trial [0.03%]
急性ST段抬高型心肌梗死患者行经皮冠状动脉介入治疗时静脉注射与冠状动脉内注射依替巴肽的比较：随机对照试验
Hamid Reza Sanati,Ali Zahedmehr,Ata Firouzi et al.
Hamid Reza Sanati et al.
Although aspirin and clopidogrel seem to be quite enough during low risk percutaneous coronary intervention (PCI), the combination may need some reinforcement in complex situations such as primary PCI. By modifying the route and also the du...
Randomized Controlled Trial
Cardiovascular intervention and therapeutics. 2017 Oct;32(4):351-357. DOI:10.1007/s12928-016-0418-9 2017
Contemporary sex differences among patients with acute coronary syndrome treated by emergency percutaneous coronary intervention [0.03%]
急性冠脉综合征急诊经皮冠状动脉介入治疗的性别差异分析
Hideki Wada,Manabu Ogita,Katsumi Miyauchi et al.
Hideki Wada et al.
Acute coronary syndrome (ACS) is an important cause of mortality and morbidity in the general population. Recent advances in percutaneous coronary intervention (PCI) and optimal medical treatment have helped to improve the prognosis of pati...
Observational Study
Cardiovascular intervention and therapeutics. 2017 Oct;32(4):333-340. DOI:10.1007/s12928-016-0416-y 2017
Changes in P2Y12 reaction units after switching treatments from prasugrel to clopidogrel in Japanese patients with acute coronary syndrome followed by elective coronary stenting [0.03%]
急性冠脉综合征患者接受药物洗脱支架植入术的择期冠状动脉成形术后更换氯吡格雷导致普拉格雷P2Y12反应单位变化：一项日本多中心研究
Takafumi Ueno,Hiroshi Koiwaya,Ken-Ichiro Sasaki et al.
Takafumi Ueno et al.
Patients with ischemic heart disease are administered a dual antiplatelet therapy after percutaneous coronary intervention. This consists of aspirin and thienopyridine, which can be switched from prasugrel to clopidogrel. However, the impac...
Randomized Controlled Trial
Cardiovascular intervention and therapeutics. 2017 Oct;32(4):341-350. DOI:10.1007/s12928-016-0417-x 2017
Effectiveness of sarpogrelate after endovascular treatment for femoropopliteal artery disease: ESPALIER study [0.03%]
富血小板血浆治疗下肢动脉硬化性闭塞症的疗效：ESPALIER研究
Yoshimitsu Soga,Yoshiaki Shintani,Toshimitsu Hamasaki et al.
Yoshimitsu Soga et al.
Optimal medical therapy following endovascular therapy (EVT) for femoropopliteal (FP) lesions remains unclear. Therefore, we investigated whether sarpogrelate improves primary patency after EVT for FP lesions. This study was performed as a ...
Randomized Controlled Trial
Cardiovascular intervention and therapeutics. 2017 Oct;32(4):325-332. DOI:10.1007/s12928-016-0414-0 2017
Prospective multi-center registry to evaluate efficacy and safety of the newly developed diamond-like carbon-coated cobalt-chromium coronary stent system [0.03%]
新型类钻碳涂层钴铬合金冠脉支架系统疗效和安全性评价的前瞻性多中心注册研究
Kenji Ando,Katsuhisa Ishii,Eiji Tada et al.
Kenji Ando et al.
The purpose of this multi-center, non-randomized, and open-label clinical trial was to determine the non-inferiority of diamond-like carbon (DLC)-coated cobalt-chromium coronary stent, the MOMO DLC coronary stent, relative to commercially a...
Renal artery stenting in a 2-year-old child with resistant hypertension and neurofibromatosis [0.03%]
NF患儿难治性高血压的肾动脉支架成形术——1例2岁儿童的治疗经验
Kiron Varghese,Srilakshmi M Adhyapak,S B Lohitashwa et al.
Kiron Varghese et al.
The occurrence of vascular lesions in neurofibromatosis is uncommon but well documented. These vascular lesions when present, occur predominantly in the kidneys, endocrine glands, heart and gastrointestinal tract, causing stenosis or oblite...
Irreversible deterioration of estimated glomerular filtration rate in patients with acute myocardial infarction after primary percutaneous coronary intervention [0.03%]
急性心肌梗死患者行急诊经皮冠状动脉介入治疗后的肾小球滤过率持续性恶化
Kenya Saji,Shigeto Namiuchi,Tadashi Sugie et al.
Kenya Saji et al.
Contrast-induced nephropathy is a possible complication after primary percutaneous coronary intervention (PCI) for acute myocardial infarction (MI). Deterioration of renal function is reported to be generally reversible. However, renal insu...